Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia - Test2 - elhamkhani - TriplyDB

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

http://www.wikidata.org/entity/Q36422681

about

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.Ceftaroline fosamil: a brief clinical review.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Vancomycin revisited - 60 years later Clinical management of Staphylococcus aureus bacteremia: a review.Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.Invasive gram-positive bacterial infection in cancer patients.Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures Nonculture techniques for the detection of bacteremia and fungemia.Rapid and accurate identification of human-associated staphylococci by use of multiplex PCR.Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?Direct Identification of Staphylococcus aureus and Determination of Methicillin Susceptibility From Positive Blood-Culture Bottles in a Bact/ALERT System Using Binax Now S. aureus and PBP2a Tests Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.Staph ID/R: a rapid method for determining staphylococcus species identity and detecting the mecA gene directly from positive blood culture.Predictors of mortality in Staphylococcus aureus Bacteremia Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance Rapid Diagnosis of Staphylococcal Catheter-Related Bacteraemia in Direct Blood Samples by Real-Time PCR.Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of Staphylococcus aureus in positive blood cultures.Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.A current perspective on daptomycin for the clinical microbiologist.Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing Service.A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures.

P2860

Q21261829-219EC18B-7B41-4295-BB22-173A56705DFD Q26779453-6B1FC021-369E-4D66-9DE8-9F559BB566BB Q33437851-8FF8CA35-EE99-4AC6-9B55-819BDE372880 Q33483064-2A94CD41-6F86-4805-8685-A200D1118DD4 Q33700986-2ACA5A10-FB1C-457E-8301-304528F8A677 Q33704733-3FD95FE9-36E7-4B6C-A48D-12E9A5D3EEB1 Q33939080-8610761B-7D7E-4602-8466-39078E87DB3D Q34100226-066DCB5E-6E6A-4FC2-9CC4-3DF955581CC2 Q34157657-FB7B5E37-E14D-477A-948C-7076625A40B5 Q34433066-CDA8F3CF-5914-4DBE-954E-49C4E3EAEF73 Q34441035-B6F34AF3-DF3A-4445-BABB-60DD31220212 Q34463444-FD0F604E-704C-4103-AB34-EB3A140C0F5A Q34478074-116B62DA-8EED-49F3-922A-34AED97090A2 Q34737617-7340A1EE-6CF8-4CB3-AC03-0F70360F8C0F Q34999884-24C10733-406F-4E37-BBE1-CFDB652197A7 Q35165032-ACF64FE5-0A17-4F1B-AB89-A336F4114DA4 Q35165426-97E0ED20-DFED-40BF-A0D8-55EF42623327 Q35273313-B2984359-2DAD-4F06-B944-CFA6111242A5 Q35364152-18C1D721-0BDE-4FDE-A72D-11DD5DC04065 Q35657369-8809A0DC-38B1-42EC-B8D6-AE00F2BC0EA0 Q35668314-58260EE6-82D4-4DFA-A324-137ACAFE6AFD Q35806865-490EFA84-5CCE-4D03-9ED2-261D46CA0813 Q35940556-A62720C0-DDE7-41E5-91D6-D2383A3B07DD Q35960730-334110AE-F47B-4369-A8A1-6242BFEAEF85 Q36026942-8479AAD2-2BA9-4227-964E-5C5C7818D4B7 Q36082891-D3893762-4BB3-4D19-954C-A28039BFDAD8 Q36089167-32D91712-81DF-48DC-B4EC-C1C6A4AA08D5 Q36115773-983D2748-D996-4672-8D63-6CC7B4D824AB Q36157258-40BDAC82-6B48-40DD-9A9B-121683DA9D4B Q36165152-623CF102-8B1F-4BB7-8705-AD3CA985CC87 Q36181397-58273289-DC1D-4DE8-9622-51ABA0356322 Q36558322-0AD1640B-4AE6-4816-9AF7-C863A83A1CA8 Q36576652-2F7CD69B-6B2C-4246-8644-FFF84699AC74 Q36836505-42D6878D-B310-4F98-B147-4DC7628E7683 Q36856946-7F7622E5-85C3-4C42-9C60-2C300EEF807B Q36884496-BB6FB0FC-F565-442B-A003-6F6CA3463674 Q36972978-BDE9B4D2-C6D4-4307-ACFA-C01741D60C50 Q37263289-4A66BA4B-719E-478A-B863-737629DF9B1B Q37305626-FD759CB9-0AE0-4144-A576-9FA64C703C1A Q37444795-07827345-022E-406B-A64A-388DA3C1F5DB

P2860

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

http://www.wikidata.org/entity/Q36422681

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@ast

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@en

type

label

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@ast

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@en

prefLabel

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@ast

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@en

P1433

Q36422681-404F5F13-CD65-4ACC-A2FE-DD5F34520220

P1476

Q36422681-655BE1A5-4D34-44E6-9AE8-AD12B3C11545

P2093

Q36422681-36F122DF-F092-40EB-9E0C-6802CD553101

Q36422681-B10071BF-CDEC-4DAC-83E2-42B0BDCA54E3

Q36422681-B192C4ED-F4D7-4339-B054-3B4133832DDE

Q36422681-B6EC9644-3410-4BCB-9309-9FF834794A16

Q36422681-E2EC2E3C-02F2-444A-8991-7E0259E18865

P2860

Q36422681-05337E23-5A1A-47DA-AD3F-A90407B4BA07

Q36422681-0AC081FF-BFC3-4403-A589-D4041F65C637

Q36422681-0F83FB96-3424-4608-A521-61D7A26D2F3F

Q36422681-178A58E2-338D-40CA-A5F8-86573ACF0A9A

Q36422681-24739199-C63D-4527-A2FD-71A20BC85A7B

Q36422681-2BA13C2B-5989-4771-81D0-D6B6B798ADC4

Q36422681-2D8DB06C-E01C-445F-B7A9-F854EDD378E9

Q36422681-58D7BAD1-0D68-406D-95CC-A9C9D0DDB71B

Q36422681-71F9514E-B23B-406B-8BB1-FFD5769C1C88

Q36422681-72BFDF7F-0F1E-4054-843E-C60D6B01C8A1

P304

Q36422681-B32380D9-3F2A-4052-BAC7-A00E9AE9CD33

P31

Q36422681-3F2A5575-0801-4476-B357-FB6C357668C8

P356

Q36422681-606D2E3C-C792-495A-A6DB-0D06D1344A3D

P407

Q36422681-6F8BB7B0-AE57-4982-BA2F-993B7B2ACD23

P433

Q36422681-5020E216-07B6-4B67-B81B-0EEEFD55FBBE

P478

Q36422681-5951265E-124F-4150-BA50-A0AE2D472E73

P50

Q36422681-01F435BA-492A-4267-87EE-32747E3BA5A3

Q36422681-DEDB6170-AE40-40D6-B2D2-A733AC69869B

P577

Q36422681-AC271715-A9DE-4E00-BB85-9012D7CB35E8

P698

Q36422681-053A86C5-1697-4F0B-AB0B-94BDEFFE4ADA

P932

Q36422681-5E23821F-B54B-47D6-AAA7-AFDC96E29CA5

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia

@en

P2093

Eui-Chong Kim

http://www.w3.org/2001/XMLSchema#string

Kang-Won Choe

http://www.w3.org/2001/XMLSchema#string

Kye-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Nam-Joong Kim

http://www.w3.org/2001/XMLSchema#string

Sung-Han Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

Staphylococcus aureus bacteremia and endocarditis.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.

A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.

Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia.

Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.

P304

192-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00700-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17984229

http://www.w3.org/2001/XMLSchema#string

P932

2223910

http://www.w3.org/2001/XMLSchema#string